158 related articles for article (PubMed ID: 6296742)
21. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy.
Luciano AA; De Souza MJ; Roy MP; Schoenfeld MJ; Nulsen JC; Halvorson CV
J Reprod Med; 1993 Mar; 38(3):207-14. PubMed ID: 8487239
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
[TBL] [Abstract][Full Text] [Related]
24. Dysfunctional uterine bleeding.
Boyd ME
Can J Surg; 1986 Sep; 29(5):305-7. PubMed ID: 3019496
[TBL] [Abstract][Full Text] [Related]
25. Hormonal pathology of the endometrium.
Deligdisch L
Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
[TBL] [Abstract][Full Text] [Related]
26. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
27. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
[TBL] [Abstract][Full Text] [Related]
28. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-progestin pharmacodynamics of the postmenopausal endometrium studied by thymidine labeling.
Friedrich ER; Meyer JS
Am J Obstet Gynecol; 1982 Jun; 143(3):352-9. PubMed ID: 6282125
[TBL] [Abstract][Full Text] [Related]
30. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
[TBL] [Abstract][Full Text] [Related]
31. Endometrial cytology in postmenopausal hormone replacement therapy.
Kaba S; Aoki T; Fukatsu T
Diagn Cytopathol; 1998 Sep; 19(3):161-7. PubMed ID: 9740987
[TBL] [Abstract][Full Text] [Related]
32. Cyclic therapy resulted in pregnancy in premature ovarian failure.
Ohsawa M; Wu MC; Masahashi T; Asai M; Narita O
Obstet Gynecol; 1985 Sep; 66(3 Suppl):64S-67S. PubMed ID: 2410842
[TBL] [Abstract][Full Text] [Related]
33. The endometrial nucleolar channel system as an indicator of progestin potency in HRT.
Ryder TA; Mobberley MA; Whitehead MI
Maturitas; 1995 Jun; 22(1):31-6. PubMed ID: 7666814
[TBL] [Abstract][Full Text] [Related]
34. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral conjugated equine estrogen combined with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women.
Hsu SC; Liu CM; Long CY; Yang CH; Lee JN; Tsai EM
Fertil Steril; 2005 Oct; 84(4):1037-9. PubMed ID: 16213869
[TBL] [Abstract][Full Text] [Related]
36. Optimizing the dose of hormone replacement therapy.
Rice VM
Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
[TBL] [Abstract][Full Text] [Related]
37. The effects of estrogens and progestogens on the endometrium. Modern approach to treatment.
Whitehead MI; Fraser D
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):299-320. PubMed ID: 3306523
[TBL] [Abstract][Full Text] [Related]
38. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
Neumannová M; Kauppila A; Kivinen S; Vihko R
Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
[TBL] [Abstract][Full Text] [Related]
39. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
